Ultra-rapid lispro is more protective against exercise-associated hypoglycaemia over lispro in adults with type 1 diabetes on continuous subcutaneous insulin infusion

被引：0
|
作者：
Leohr, J. [1 ]
Abibol, A. [2 ]
LaBell, E. Smith [1 ]
Ghosh, A. [1 ]
Turner, L. V. [3 ]
Shakeri, D. [3 ]
Fukuda, T. [1 ]
Riddell, M. C. [2 ,3 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] LMC Healthcare, Centr Res, Toronto, ON, Canada
[3] York Univ, Muscle Hlth Res Ctr, Toronto, ON, Canada
来源：
DIABETOLOGIA | 2023年 / 66卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
12
引用
收藏
页码：S9 / S9
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of ultra-rapid lispro compared to insulin lispro in adults with type 1 diabetes
    Zhou, Z.
    Ma, J.
    Lei, T.
    An, Z.
    Xue, Y.
    Manghi, F. P.
    Garcia, P.
    Xu, J.
    Yuan, Y.
    Yan, X.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S364 - S364
  • [2] Improved postprandial glucose control with Ultra Rapid Lispro (URLi) versus Lispro with continuous subcutaneous insulin infusion in type 1 diabetes
    Warren, M.
    Cho, J.
    Liu, R.
    Tobian, J.
    Ignaut, D.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S29 - S30
  • [3] Faster recovery from hyperglycaemia with ultra rapid lispro vs lispro in patients with type 1 diabetes on continuous subcutaneous insulin infusion
    Leohr, J.
    Dellva, M. A.
    LaBell, E.
    Arrubla, J.
    Plum-Moerschel, L.
    Zijlstra, E.
    Fukuda, T.
    Hardy, T.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 263 - 264
  • [4] Vitiligo associated with subcutaneous insulin lispro infusion in type 1 diabetes
    Burge, MR
    Carey, JD
    DIABETES CARE, 2004, 27 (01) : 275 - 276
  • [5] Improved postprandial glucose control with ultra rapid lispro versus lispro with continuous subcutaneous insulin infusion in type 1 diabetes: PRONTO-Pump-2
    Warren, Mark
    Bode, Bruce
    Cho, Jang I.
    Liu, Rong
    Tobian, Janet
    Hardy, Thomas
    Chigutsa, Farai
    Phillip, Moshe
    Horowitz, Barry
    Ignaut, Debra
    DIABETES OBESITY & METABOLISM, 2021, 23 (07): : 1552 - 1561
  • [6] Assessing infusion site reactions with ultra rapid lispro in continuous subcutaneous insulin infusion
    Ignaut, D.
    Cho, J.
    Elpers, J.
    Chigutsa, F.
    de Oliveira, C. Piras
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 265 - 265
  • [7] CONTINUOUS SUBCUTANEOUS INFUSION OF INSULIN LISPRO IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS
    Kaiserman, Kevin
    Rodriguez, Henry
    Stephenson, Amanda
    Wolka, Linda
    Fahrbach, Jessie L.
    ENDOCRINE PRACTICE, 2012, 18 (03) : 418 - 424
  • [8] Compatibility and Safety of Ultra Rapid Lispro with Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: PRONTO-Pump Study
    Bode, Bruce
    Garg, Satish
    Norwood, Paul
    Morales, Cristobal
    Hardy, Thomas
    Liu, Rong
    Ignaut, Debra
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 (01) : 41 - 50
  • [9] IMPROVED POSTPRANDIAL GLUCOSE (PPG) CONTROL WITH ULTRA RAPID LISPRO (URLI) VERSUS LISPRO WITH CONTINUOUS SUBCUTANEOUS INSULIN INFUSION (CSII) IN TYPE 1 DIABETES (T1D)
    Warren, M.
    Cho, J.
    Liu, R.
    Tobian, J.
    Ignaut, D.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A22 - A23
  • [10] Ultra Rapid Lispro (URLi) accelerates insulin lispro absorption and insulin action vs lispro in patients with type 1 diabetes
    Linnebjerg, H.
    Zhang, Q.
    LaBell, E.
    Reddy, S.
    Coutant, D.
    Bowerman, S.
    Hoevelmann, U.
    Plum-Moerschel, L.
    Herbrand, T.
    Leohr, J.
    DIABETOLOGIA, 2019, 62 : S382 - S383
12345